hotspot -WSS

hotspot

author：explore 2025-10-02 21:06:15 - browse：45

Human embryonic stem cells Annie Cavanagh/Wellcome Images

The Food and Drug Administration on Thursday unveiled a series of guidelines that aim to encourage the development of promising and legitimate stem cell therapies while distinguishing them from the largely untested stem cell treatments hawked by unregulated clinics around the country.

The FDA’s guidelines have been expected and eagerly awaited by the stem cell community given the rapid proliferation of untested — and potentially unsafe — therapies around the country. Clinics promoting these therapies claim to be able to treat ailments from autism to neurodegenerative disorders to erectile dysfunction.

The guidelines also spell out how the agency will implement the regenerative medicine provisions in a behemoth law enacted last year called the 21st Century Cures Act.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： J&J expands global access to TB drug amid advocacy campaign

WSS

Pfizer plans to depart BIO

Congress: Eradicate hepatitis C and reduce the deficit

Global childhood vaccinations edge closer to pre

Congenital heart disease patients face new threat of heart failure

Blood tests recalled over risk of missed heart attack diagnosis

Why sickle cell disease is getting the first CRISPR treatment

hotspot

hotspot

Wikipedia

Affirmative action in medical school literally saved lives

Teach medical students about patients with intellectual disabilities

Medical leaders decry Supreme Court decision on affirmative action

Everything to know for the next Powerball drawing as jackpot hits $1 billion

Virginia high school admissions case could be legal follow

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

BioMarin wins approval for gene therapy to treat hemophilia A

Federal judge rules Oregon’s tough new gun law is constitutional

Activists slam private health insurers over coverage restrictions

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

explore

Woman gored by Bison at Yellowstone

In diabetes hearing, Sanders takes on a new foe: food makers

AI models in health care face new federal disclosure requirements

What PEPFAR has meant on the ground in Ukraine

FDA needs staff influx to meet gene therapy needs, Marks says

Manchin, Huntsman team up to talk platform for 'unity' ticket that could run in 2024

leisure time

hotspot

knowledge

focus